BioLine RX Ltd BLRX:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 09/17/21 EDT
2.66quote price arrow down-0.01 (-0.37%)
Volume
1,171
Close
2.67UNCH (UNCH)
Volume
160,960
52 week range
1.40 - 6.34
Loading...
  • Open2.68
  • Day High2.70
  • Day Low2.62
  • Prev Close2.67
  • 52 Week High6.34
  • 52 Week High Date05/04/21
  • 52 Week Low1.40
  • 52 Week Low Date10/28/20

Key Stats

  • Market Cap124.02M
  • Shares Out46.45M
  • 10 Day Average Volume0.33M
  • Dividend-
  • Dividend Yield-
  • Beta2.18
  • YTD % Change5.95

KEY STATS

  • Open2.68
  • Day High2.70
  • Day Low2.62
  • Prev Close2.67
  • 52 Week High6.34
  • 52 Week High Date05/04/21
  • 52 Week Low1.40
  • 52 Week Low Date10/28/20
  • Market Cap124.02M
  • Shares Out46.45M
  • 10 Day Average Volume0.33M
  • Dividend-
  • Dividend Yield-
  • Beta2.18
  • YTD % Change5.95

RATIOS/PROFITABILITY

  • EPS (TTM)-
  • P/E (TTM)-
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date11/19/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On BioLine RX Ltd

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
BioLine RX Ltd is an Israel-based clinical-stage biopharmaceutical company focused on oncology. The Company is commited into in-license novel compounds, develop them through clinical stages, and then partner with pharmaceutical companies for further clinical development andcommercialization. The Company is commited into two projects: Motixafortide (BL-8040), which is a cancer therapy platform , and AGI-134, an immunotherapy treatment.
Aharon Schwartz Ph.D.
Chairman
Philip Serlin
Chief Executive Officer
Mali Zeevi
Chief Financial Officer
Ella Sorani
Vice President
Abi Vainstein-Haras
Vice President
Address
Modi'in Technology Park
2 HaMa'ayan Street
Modiin
7177871
Israel

Top Peers

SYMBOLLASTCHG%CHG
NCNA
NuCana PLC
2.36-0.01-0.42%
IFRX
Inflarx NV
2.73+0.06+2.25%
HEPA
Hepion Pharmaceuticals Inc
1.59+0.01+0.63%
ETTX
Entasis Therapeutics Holdings Inc
3.11+0.20+6.87%
AXLA
Axcella Health Inc
3.23-0.01-0.31%